Here are relevant reports on : pet-tech-market
-
Pet Supplements Market by Functional Application (Skin & Coat, Hips & Joints, Digestive Health, Immune Support), Supplement Type (Multivitamin, Glucosamine, Antioxidants), Pet, Form, Distribution Channel, and Region - Global Forecast to 2029
According to MarketsandMarkets, the global pet supplements market is estimated to be valued at USD XXX.X million in 2024 and is projected to reach USD XXX.X million by 2029, recording a CAGR of X.X%. Key players in this market include ADM (US), Nestlé (Switzerland), Nutramax Laboratories, Inc. (US), Zoetis Services LLC (US), Virbac (France), Zesty Paws (US), These players have adopted strategies of product launches, expansions, agreements/partnerships, and mergers and acquisitions to grow in the market. All key product manufacturers that are part of the pet supplements ecosystem have been considered under the company profiles section.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Pet Treats Market by Pet Type (Dogs, Cats, Others), Ingredient Source (Animal-based, Plant-based, Alternative Proteins), Product Type, Function, Manufacturing Process, Distribution Channel, and Region - Forecast to 2031
The pet treats market is expected to grow from USD 38.40 billion in 2026 to USD 58.71 billion by 2031, at a CAGR of 8.9%. The key players include Nestlé Purina PetCare (Switzerland), Mars, Incorporated and its Affiliates (US), General Mills Inc. (US), The J.M. Smucker Company (US), Colgate-Palmolive (US), Wellness Pet Company LLC (US), Spectrum Brands (US), and Simmons Pet Food (US).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028
The global multimodal imaging market, valued at US$3.9 billion in 2022, stood at US$4.2 billion in 2023 and is projected to advance at a resilient CAGR of 5.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.5 billion by the end of the period.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Pet Food Palatants Market - Global Forecast to 2029
Pet Food Palatants Market
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Probiotic and Prebiotic Pet Foods Market - Global Forecast to 2029
The Probiotic and Prebiotic Market is estimated at USD XX billion in 2024 and is projected to reach USD XX billion by 2029, at a CAGR of XX% from 2024 to 2029. Key players operating in the food and beverage metal cans equipment market include Probi (Sweden), Royal Canin (France), Nestlé Purina PetCare(US), Mars Inc. CHR. Hansen (Denmark), Kinglike DSM N.V (Netherlands), Dow DuPont (US), Evonik Industries (Germany) . These players in this market are focusing on increasing their presence through expansion and collaboration. These companies have a strong presence in North America, Asia Pacific, and Europe.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Pet Food Flavors Market - Global Forecast to 2029
Pet Food Flavors Market
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Grain-Free Pet Foods Market By Pet Types (Dogs, Cats, And Other Companion Pets), Product Type (Dry Pet Food, Wet Pet Food, Treat & Supplements), Distribution Channel (Modern Trade, Departmental Stores, Pet Specialty Stores, Online Retailers, And Other Channels), Ingredient Type (Meat-Based, Plant-Based And Alternative Protein Sources), And Region - Global Forecast to 2029
The global grain-free pet foods market growth is on a trajectory of significant expansion, with an estimated value projected to reach USD XX billion by 2029 from the 2024 valuation of USD XX billion, displaying a promising Compound Annual Growth Rate (CAGR) of XX%. The key players in this market include Blue Buffalo Company, Ltd. (US), Wellness Pet, LLC (US ), SCHELL & KAMPETER, INC. (US), Nulo (US), GoDaddy Operating Company, LLC. (US), Canidae (US), Nestlé S.A. (Switzerlands), Farmina Pet Foods (Italy), Mars, Incorporated (US), and Dr. Tim's Pet Food Company (US).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Medical Image Analysis Software Market by Function (Reconstruction, Detection, Analysis, Reporting), Tech (AI [ML, Computer Vision), Image (3D, 4D), Modality (CT, PET/SPECT, Mammo), Indication (Onco, Cardio), End User (Hospital) - Global Forecast to 2031
The global medical image analysis software market is projected to reach USD 6.42 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
